BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38698303)

  • 1. Construction of oxidative phosphorylation-related prognostic risk score model in uveal melanoma.
    Zhan Z; Lin K; Wang T
    BMC Ophthalmol; 2024 May; 24(1):204. PubMed ID: 38698303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and Functional Analysis of
    Mei S; Li Y; Kang X
    Dis Markers; 2022; 2022():4143447. PubMed ID: 35432628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of differentially expressed genes and functional annotations associated with metastases of the uveal melanoma.
    Xu Y; Han W; Xu WH; Wang Y; Yang XL; Nie HL; Yao J; Shen GL; Zhang XF
    J Cell Biochem; 2019 Nov; 120(11):19202-19214. PubMed ID: 31270856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
    Liu J; Lu J; Li W
    Front Immunol; 2021; 12():738068. PubMed ID: 34630418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of a costimulatory molecule-related signature to predict the prognosis for uveal melanoma patients.
    Zhao M; Yu Y; Song Z
    Sci Rep; 2024 Apr; 14(1):9146. PubMed ID: 38644411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data.
    Wang W; Zhao H; Wang S
    Front Immunol; 2023; 14():1099071. PubMed ID: 36793711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Glycolysis-Related Signature for Predicting the Prognosis and Immune Infiltration of Uveal Melanoma.
    Guo X; Yu X; Zhang Y; Luo H; Huang R; Zeng Y; Duan C; Chen C
    Ophthalmic Res; 2023; 66(1):692-705. PubMed ID: 36858025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analysis of Enhancer RNAs Identifies LINC00689 and ELFN1-AS1 as Novel Prognostic Biomarkers in Uveal Melanoma.
    Zhao S; Jiang H; Liu J; Li DY; Li B; Long QR; Zheng L; Gu H
    Dis Markers; 2022; 2022():5994800. PubMed ID: 35251374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating DNA damage response in uveal melanoma through embryonic stem cell microenvironment.
    Zhang Y; Zheng J; Chen M; Zhao S; Ma R; Chen W; Liu J
    BMC Cancer; 2024 Apr; 24(1):519. PubMed ID: 38654216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Necroptosis-Related Prognostic Model of Uveal Melanoma Was Constructed by Single-Cell Sequencing Analysis and Weighted Co-Expression Network Analysis Based on Public Databases.
    Xie J; Chen L; Tang Q; Wei W; Cao Y; Wu C; Hang J; Zhang K; Shi J; Wang M
    Front Immunol; 2022; 13():847624. PubMed ID: 35242144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An autophagy-related prognostic signature associated with immune microenvironment features of uveal melanoma.
    Zheng Z; Zhang L; Tu Z; Deng Y; Yin X
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33682883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Survival-Related Metabolic Genes and a Novel Gene Signature Predicting the Overall Survival for Patients with Uveal Melanoma.
    Guo X; Yu X; Li F; Xia Q; Ren H; Chen Z; Xing Y
    Ophthalmic Res; 2022; 65(5):516-528. PubMed ID: 35390784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a prognostic model using cuproptosis-related genes in uveal melanoma.
    Chen Y; Chen X; Wang X
    Front Cell Dev Biol; 2022; 10():973073. PubMed ID: 36111345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of prognostic genes in uveal melanoma microenvironment.
    Luo H; Ma C
    PLoS One; 2020; 15(11):e0242263. PubMed ID: 33196683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High EIF4E2 expression is an independent prognostic risk factor for poor overall survival and recurrence-free survival in uveal melanoma.
    Yang B; Gu A; Wu Y
    Exp Eye Res; 2021 May; 206():108558. PubMed ID: 33785306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decoding tumor heterogeneity in uveal melanoma: basement membrane genes as novel biomarkers and therapeutic targets revealed by multi-omics approaches for cancer immunotherapy.
    Li Y; Cai H; Yang J; Xie X; Pei S; Wu Y; Zhang J; Song G; Zhang J; Zhang Q; Chi H; Yang G
    Front Pharmacol; 2023; 14():1264345. PubMed ID: 37822877
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic values of Annexins and validation of the influence on cell proliferation, migration, and invasion in uveal melanoma.
    Zhao A; Wang Z; Wang Y; Chen X
    Am J Transl Res; 2023; 15(5):3131-3151. PubMed ID: 37303667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an immune and stromal prognostic signature in uveal melanoma to guide clinical therapy.
    Gong Q; Wan Q; Li A; Yu Y; Ding X; Lin L; Qi X; Hu L
    Aging (Albany NY); 2020 Oct; 12(20):20254-20267. PubMed ID: 33100273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and validation of a pyroptosis-related gene signature associated with the tumor microenvironment in uveal melanoma.
    Zhang F; Deng Y; Wang D; Wang S
    Sci Rep; 2022 Jan; 12(1):1640. PubMed ID: 35102195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-omics approaches identify novel prognostic biomarkers of autophagy in uveal melanoma.
    Jin W; Wu L; Hu L; Fu Y; Fan Z; Mou Y; Ma K
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16691-16703. PubMed ID: 37725244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.